William Febbo | Chief Executive Officer |
Edward Stelmakh | Chief Financial and Operating Officer |
Stephen Silvestro | Chief Commercial Officer |
Marion Odence-Ford | General Counsel and Chief Compliance Officer |
Andrew D’Silva | Senior Vice President, Corporate Finance |
Ryan Daniels | William Blair |
Sean Dodge | RBC Capital Markets |
Eric Martinuzzi | Lake Street |
Good afternoon, everyone. And thank you for joining OptimizeRx’s Second Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by company Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer; Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva.
At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call.